CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |
SVB FINANCIAL GROUP | 13,516 | $122,320 | 0.23% |
Rubric Capital Management LP | 626,929 | $5,673,707 | 0.21% |
Birchview Capital, LP | 25,114 | $227,282 | 0.19% |
KENNEDY CAPITAL MANAGEMENT LLC | 489,446 | $4,429,486 | 0.11% |
Orbimed Advisors | 544,848 | $4,930,874 | 0.10% |
AMERICAN INTERNATIONAL GROUP, INC. | 1,235,592 | $11,182,108 | 0.07% |
Virtus ETF Advisers LLC | 8,404 | $76,056 | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 18,591 | $168,249 | 0.03% |
Annandale Capital, LLC | 12,000 | $109 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $10,407,500 | 0.02% |
External links
This page lists CULLINAN ONCOLOGY INC's shareholders in Q3 2023. To view CULLINAN ONCOLOGY INC's shareholder history, click here.